Compare KRMD & MITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRMD | MITT |
|---|---|---|
| Founded | 1980 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 272.8M | 287.6M |
| IPO Year | N/A | 2011 |
| Metric | KRMD | MITT |
|---|---|---|
| Price | $5.61 | $8.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | $6.00 | ★ $9.04 |
| AVG Volume (30 Days) | 143.9K | ★ 185.5K |
| Earning Date | 03-11-2026 | 03-02-2026 |
| Dividend Yield | N/A | ★ 10.40% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.94 |
| Revenue | $39,070,637.00 | ★ $87,678,000.00 |
| Revenue This Year | $23.97 | N/A |
| Revenue Next Year | $18.20 | $16.68 |
| P/E Ratio | ★ N/A | $9.43 |
| Revenue Growth | ★ 22.12 | 8.59 |
| 52 Week Low | $1.86 | $5.63 |
| 52 Week High | $6.61 | $9.27 |
| Indicator | KRMD | MITT |
|---|---|---|
| Relative Strength Index (RSI) | 49.03 | 52.53 |
| Support Level | $5.56 | $8.76 |
| Resistance Level | $5.85 | $9.16 |
| Average True Range (ATR) | 0.30 | 0.23 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 59.04 | 52.04 |
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
TPG Mortgage Investment Trust Inc is a real estate investment trust (REIT). It focuses on investing in a diversified risk-adjusted portfolio of residential mortgage-related assets in the U.S. mortgage market. Its objective is to provide attractive risk-adjusted returns to its stockholders over the long term through dividends and capital appreciation.